bioMerieux -- Press Releases

New apiweb from bioMérieux INDUSTRY Brings Instant Internet Access to api^®, ID32 and Rapid ID32 Results

St.Louis, MO - May 4, 2004. The api^® product family, which revolutionized identification of bacteria by miniaturizing and standardizing conventional biochemicals, now has Internet support. The new apiweb service from bioMérieux INDUSTRY offers instant access to interpretation of api, ID32 and Rapid ID32 strip results directly on an Internet server. The software allows fast, simple and user-friendly microorganism identification.

The first identification software available on the Internet, apiweb is within the capabilities of every laboratory using api products. It is available at all times without technical constraints that might be associated with the rapid evolution of data processing platforms. Software functionalities include strip selection, profile data input, result display, result printing and result export. For laboratories without Internet access, the software is available on CD-ROM.

A few of apiweb's features and benefits include:

No need for profile indices for an environmentally friendly reduction in paper use
Ease of use – either profile number or reaction pattern can be entered
Immediate and free implementation of database updates
Visual guide to interpretation of positive and negative results

For more information about apiweb and the api family of products, call bioMérieux INDUSTRY, 1-800-634-7656.

About bioMérieux INDUSTRY

bioMérieux INDUSTRY provides product solutions to quality control and research microbiology laboratories. Applications served include environmental monitoring, sterility testing, pathogen screening, quality indicators, microbial identification, quality control organisms, microbial limits and preservative effectiveness testing.

About bioMérieux

A global leader in disease prevention and management, bioMérieux provides assays, reagents and instrumentation for clinical microbiology, coagulation, immunoassay, and nucleic acid diagnostics; and also for product quality control in the agri-food, cosmetics and pharmaceutical industries. Based in Marcy-l'Etoile, France, the company's U.S. headquarters is in Durham, North Carolina.

With sales of 1 billion Euros in 2003, bioMérieux ranks as the eighth largest biological diagnostics company worldwide. Over 81% of its activity takes place on an international level. Investment in research and development represents 13% of sales.

bioMérieux, employs 5400 people throughout the world, including 3200 in Europe and 1500 in the US . The group has 15 production sites distributed in France, the United States, Brazil, Italy and the Netherlands, as well as a European logistics center in France.

Already present in over 130 countries, with more than 110 distributors and 32 subsidiaries, bioMérieux continues its international development by strengthening its presence in Latin America and Asia.